These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 6228317)
1. [Effect of renal hemodynamics, aldosterone and other factors on ascites formation in schistosomiasis]. Yang JS; Fu S; Yang YQ; Qian YD; Yu ZP; Xu RG; Jin JP; Jiang JM Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Aug; 5(4):235-9. PubMed ID: 6228317 [No Abstract] [Full Text] [Related]
2. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems. Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749 [TBL] [Abstract][Full Text] [Related]
3. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites. Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457 [TBL] [Abstract][Full Text] [Related]
6. The acute effects of sustained volume expansion on the renin-aldosterone system and renal function in human hepatic ascites. Greig PD; Blendis LM; Langer B; Ruse J; Taylor BR J Lab Clin Med; 1981 Jul; 98(1):127-34. PubMed ID: 7019366 [TBL] [Abstract][Full Text] [Related]
7. [Research on arterial hypertension. Significance of aldosterone, catecholamines, amino acids and some electrolytes in compensated and decompensated cardiac lesions]. Manta I; Hodîrnău A; Proinov I; Băltescu V; Schneider E Med Interna (Bucur); 1970 Jul; 22(7):807-20. PubMed ID: 5506380 [No Abstract] [Full Text] [Related]
8. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites. Kalambokis G; Economou M; Fotopoulos A; Al Bokharhii J; Pappas C; Katsaraki A; Tsianos EV Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036 [TBL] [Abstract][Full Text] [Related]
9. Renal function after elective hepatic resection. Matsumata T; Taketomi A; Fujiwara Y; Shimada M; Takenaka K; Sugimachi K Hepatogastroenterology; 1996; 43(9):602-7. PubMed ID: 8799403 [TBL] [Abstract][Full Text] [Related]
10. [State of the central and renal hemodynamics, of electrolyte metabolism and of the renin-aldosterone system in chronic diseases of the small intestine]. Khodarev NN; Filatov VI; Iosava LI Ter Arkh; 1980; 52(2):75-9. PubMed ID: 6990535 [No Abstract] [Full Text] [Related]
11. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Quiroga J; Sangro B; Núñez M; Bilbao I; Longo J; García-Villarreal L; Zozaya JM; Betés M; Herrero JI; Prieto J Hepatology; 1995 Apr; 21(4):986-94. PubMed ID: 7705810 [TBL] [Abstract][Full Text] [Related]
12. [Role of disorders in the functional state of the kidneys and in electrolyte balance in the pathogenesis of vibration disease (a clinical and experimental study)]. Dynnik VI; Prillipskiĭ IuV; Krivitskaia GL Gig Tr Prof Zabol; 1975 Sep; (9):32-6. PubMed ID: 1176017 [No Abstract] [Full Text] [Related]
13. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites. Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of ascites in cirrhosis and portal hypertension. Heneghan MA; Harrison PM Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of intractable ascites in schistosomiasis by mesocaval shunt after concentration and reinfusion of ascitic fluid (author's transl)]. Xue GH Zhonghua Wai Ke Za Zhi; 1981 Sep; 19(9):533-5. PubMed ID: 7338109 [No Abstract] [Full Text] [Related]
18. Effect of dipyridamole on kidney function in cirrhosis. Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042 [TBL] [Abstract][Full Text] [Related]
19. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites. Wong W; Liu P; Blendis L; Wong F Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381 [TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Somberg KA; Lake JR; Tomlanovich SJ; LaBerge JM; Feldstein V; Bass NM Hepatology; 1995 Mar; 21(3):709-16. PubMed ID: 7875668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]